Loading stock data…
$0.32-0.00 (-1.33%)
Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. in the Healthcare sector is trading at $0.32 with a market capitalization of $45M. Wall Street consensus targets $1.03 (3 analysts), implying a +222.9% move over the next 12 months. The stock is currently near its 52-week low of $0.27, remaining 34.7% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 12 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $23.03M↑ | $20.88M↓ | $32.36M↓ | $33.26M↓ | $35.41M |
| Gross Profit | $13.33M↑ | $11.97M↓ | $17.75M↓ | $21.99M↓ | $24.28M |
| Operating Income | -$4.17M↓ | -$2.92M↓ | -$944,000↓ | $2.54M↓ | $4.62M |
| Net Income | -$9.41M↓ | -$3.09M↓ | $57,000↓ | $1.31M↓ | $3.55M |
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect ...